These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 3832667
1. Tumor inhibition by ferricenium complexes: systemic effect in vivo and cell growth inhibition in vitro. Köpf-Maier P. Z Naturforsch C Biosci; 1985; 40(11-12):843-6. PubMed ID: 3832667 [Abstract] [Full Text] [Related]
2. Ferricenium complexes: a new type of water-soluble antitumor agent. Köpf-Maier P, Köpf H, Neuse EW. J Cancer Res Clin Oncol; 1984; 108(3):336-40. PubMed ID: 6511806 [Abstract] [Full Text] [Related]
10. Antitumor effectiveness and mechanism of action of Ru(II)/amino acid/diphosphine complexes in the peritoneal carcinomatosis progression. Mello-Andrade F, da Costa WL, Pires WC, Pereira FC, Cardoso CG, Lino-Junior RS, Irusta VRC, Carneiro CC, de Melo-Reis PR, Castro CH, Almeida MAP, Batista AA, Silveira-Lacerda EP. Tumour Biol; 2017 Oct; 39(10):1010428317695933. PubMed ID: 29019283 [Abstract] [Full Text] [Related]
11. Synthesis, structure, electrochemistry and spectral characterization of (D-glucopyranose)-4-phenylthiosemicarbazide metal complexes and their antitumor activity against Ehrlich ascites carcinoma in Swiss albino mice. Sathisha MP, Budagumpi S, Kulkarni NV, Kurdekar GS, Revankar VK, Pai KS. Eur J Med Chem; 2010 Jan; 45(1):106-13. PubMed ID: 19854545 [Abstract] [Full Text] [Related]
13. Inhibition of Ehrlich ascites tumor in vivo by PAF-antagonists. Fecchio D, Russo M, Sirois P, Braquet P, Jancar S. Int J Immunopharmacol; 1990 Jan; 12(1):57-65. PubMed ID: 2303318 [Abstract] [Full Text] [Related]